SPDR S&P Pharmaceuticals ETF Rating $67.51 -0.50 (-0.74%) Closing price 09/11/2026 04:10 PM EasternExtended Trading$67.67 +0.16 (+0.24%) As of 09/11/2026 07:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsNews and TrendsOwnershipRatingsShort Interest SPDR S&P Pharmaceuticals ETF Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.XPH Aggregate RatingModerate Buy 2.68Holdings in XPH have an aggregate rating of Moderate Buy based on 309 analyst ratings issued in the past year covering 25 companies (53.0% of the portfolio).XPH Aggregate Price Target$67.51High Prediction$67.51Average Prediction$67.51Low Prediction$67.51Holdings in XPH have an aggregate price target of $67.51 and a range of $67.51 to $67.51 covering 25 companies (53.0% of the portfolio).XPH Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy5 Buy rating(s)Moderate Buy16 Moderate Buy rating(s)Hold4 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by SPDR S&P Pharmaceuticals ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 25 XPH Holdings ExportWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings3.98%AMLXAmylyx Pharmaceuticals$31.62-1.5%3.938 of 5 stars3.00$36.50 15.4%11Positive News3.43%CRNXCrinetics Pharmaceuticals$84.951.5014 of 5 stars2.24$81.00 -4.6%17Positive News3.07%MBXMBX Biosciences$59.02-3.2%2.8554 of 5 stars2.77$77.00 30.5%13Positive News2.74%DFTXDefinium Therapeutics$38.89+3.1%3.0168 of 5 stars3.00$63.00 62.0%20Analyst Forecast2.71%ATAIAtai Beckley$7.352.759 of 5 stars2.06$10.56 43.6%16News CoverageAnalyst UpgradeOptions Volume2.50%OMEROmeros$18.28-1.7%4.1993 of 5 stars2.67$38.00 107.9%6Positive News2.23%ELVNEnliven Therapeutics$54.32-3.4%2.5739 of 5 stars2.78$75.00 38.1%9Positive News2.20%NUVBNuvation Bio$6.11-2.8%2.7177 of 5 stars2.69$13.00 112.9%132.12%CORTCorcept Therapeutics$112.79-1.9%4.1798 of 5 stars2.50$138.17 22.5%8Positive NewsAnalyst Downgrade2.02%ETONEton Pharmaceuticals$57.08-1.4%4.4069 of 5 stars2.50$67.50 18.3%6Positive News1.96%EWTXEdgewise Therapeutics$44.40+3.5%2.8728 of 5 stars2.82$50.33 13.4%11Positive News1.95%TRVITrevi Therapeutics$15.90-0.1%3.6155 of 5 stars3.00$27.08 70.3%13Positive News1.86%NKTRNektar Therapeutics$69.76-1.3%2.5974 of 5 stars2.77$141.50 102.8%13Analyst Forecast1.86%OCULOcular Therapeutix$10.49-1.2%3.7195 of 5 stars2.77$25.75 145.5%13Positive News1.78%MRKMerck & Co., Inc.$144.02-0.5%4.3457 of 5 stars2.68$151.32 5.1%25Trending NewsAnalyst Forecast1.74%PRGOPerrigo$13.66+0.5%3.3742 of 5 stars2.00$19.33 41.5%61.69%BMYBristol Myers Squibb$63.53-0.4%4.4849 of 5 stars2.56$66.33 4.4%25Trending NewsAnalyst ForecastOptions VolumeAnalyst Revision1.68%MAZEMaze Therapeutics$24.60-0.9%2.7387 of 5 stars3.08$66.00 168.3%12Insider TradeHigh Trading Volume1.67%TARSTarsus Pharmaceuticals$79.31-2.2%2.3775 of 5 stars2.80$92.57 16.7%10Analyst ForecastInsider Trade1.66%ALMSAlumis$9.18-7.3%3.9894 of 5 stars2.83$33.27 262.4%12Insider Trade1.66%MANEVeradermics$99.20+1.1%2.7622 of 5 stars2.67$153.00 54.2%91.64%AMRXAmneal Pharmaceuticals$17.01+0.8%3.9593 of 5 stars2.89$19.57 15.1%9Positive NewsAnalyst Forecast1.63%LGNDLigand Pharmaceuticals$284.47-1.7%3.96 of 5 stars3.00$335.75 18.0%9Positive NewsInsider Trade1.61%HROWHarrow$34.48-5.7%2.3333 of 5 stars2.67$66.38 92.5%12News CoverageAnalyst ForecastHigh Trading Volume1.60%LQDALiquidia$66.74-1.6%3.7858 of 5 stars2.45$98.08 47.0%11Analyst Downgrade This page (NYSEARCA:XPH) was last updated on 9/13/2026 by MarketBeat.com Staff. From Our PartnersALERT: Drop these 5 stocks before the market opens tomorrow!The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...Weiss Ratings | SponsoredSmall Colorado Company (Backed by Sam Altman) Could Save U.S. Power GridA small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...Altimetry | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredIran War Shock: What I Was Told In That Private MeetingYou’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...Banyan Hill Publishing | SponsoredHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | SponsoredThese gold assets are priced for $1,800 gold [it's over $4,000]Gold's major miners are generating record free cash flow, with margins as high as 75 percent even after gold's...Golden Portfolio | SponsoredYour book is insideThe "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...Profits Run | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SPDR S&P Pharmaceuticals ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share SPDR S&P Pharmaceuticals ETF With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
